Mechanism-Based Extrapolation across Biosimilar Indications, Patient Populations, Dosing Regimens, and Residual Scientific Uncertainty in Regulatory and Clinical Contexts
International Journal of Pharmaceutical Research and Allied Sciences · 2025
DOI: 10.51847/0ldc77lo94 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Research and Allied Sciences, 2025. Verfasst von Gabriel Costa und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Costa, G., Ribeiro, L., Alves, R., & Lopes, M. (2025). Mechanism-Based Extrapolation across Biosimilar Indications, Patient Populations, Dosing Regimens, and Residual Scientific Uncertainty in Regulatory and Clinical Contexts. International Journal of Pharmaceutical Research and Allied Sciences. https://doi.org/10.51847/0ldc77lo94
Vancouver
Costa G, Ribeiro L, Alves R, Lopes M. Mechanism-Based Extrapolation across Biosimilar Indications, Patient Populations, Dosing Regimens, and Residual Scientific Uncertainty in Regulatory and Clinical Contexts. International Journal of Pharmaceutical Research and Allied Sciences. 2025. doi:10.51847/0ldc77lo94
BibTeX
@article{Costa2025,
author = {Costa, Gabriel and Ribeiro, Lucas and Alves, Ricardo and Lopes, Mariana},
title = {Mechanism-Based Extrapolation across Biosimilar Indications, Patient Populations, Dosing Regimens, and Residual Scientific Uncertainty in Regulatory and Clinical Contexts},
journal = {International Journal of Pharmaceutical Research and Allied Sciences},
year = {2025},
doi = {10.51847/0ldc77lo94}
}
EUVIMED